We ensured HALO met the highest safety standards to protect school children.

BAY SHORE, N.Y. (PRWEB)
November 01, 2019

IPVideo Corporation, manufacturer of the HALO IOT Smart Sensor, today announced that they have been granted approval as a UL listed smart sensor. The award-winning vape and THC detector meets UL’s internationally recognized standards for safety and quality.

With over 120 years of experience and the development of more than 1,500 standards, Underwriters Laboratories (UL) is a widely recognized global safety science organization, providing one of the highest levels of testing and qualification. Their standards and certifications are universally recognized as important indicators of product safety, quality and reliability.

According to UL, the certification works to provide safe living and working environments through the application of safety science and to “support the production and use of products that are physically and environmentally safe.” IPVideo’s award-winning environmental sensor and vape detection technology is used every day by school districts across the U.S.

“HALO is a safety and security product designed for privacy areas like hospital rooms, school bathrooms, locker rooms and dorm rooms. It is imperative that a safety product doesn’t create a safety hazard.” stated Frank Jacovino, VP of Engineering and Product Development for IPVideo Corporation. “We ensured HALO met the highest safety standards to protect school children. In addition, we manufacture our product in the U.S. in an ITAR Certified and ISO 9001 registered facility and why we chose to go through the rigorous testing and approval process of UL. In addition to UL, the HALO IOT Smart Sensor is FCC Certified, ROHS Compliant, WEEE Compliant, Plenum rated and vandal IK10 rated.”

HALO has the unique ability to provide IoT sensing as event-based triggers to provide security in privacy concern areas where traditional security cameras and solutions are not practical. As an environmental monitoring tool, HALO uses multiple sensors together in a single intelligent platform to learn, analyze and create event alerts. HALO is the only product to detect vape and vape with THC. In addition, it can detect flammables, hazardous chemicals, air quality and changes in temperature and humidity. HALO can also detect noise level fluctuations and analyze room occupancy through light detection.

For further information regarding HALO IOT Smart Sensor and IPVideo Corporation, visit http://www.ipvideocorp.com/halo/ or call 631-969-2601.

About IPVideo Corporation

IPVideo Corporation harnesses the power of the Internet of Things (IoT) and incorporates artificial intelligence (AI) and machine learning to deliver a range of open platform physical security, sensor and audio/visual solutions that provide maximum flexibility, performance, ease-of-use and value. We design and manufacture solutions for a smarter and safer world! IPVideo Corporation is a subsidiary of Advanced Convergence Group.

Our newest product offering HALO IOT Smart Sensor is disrupting the world of physical security. As the security industry product of the year, HALO is a security device for privacy areas and an environmental monitoring tool. It’s vaping and THC detection capabilities are gaining global attention and being used by school districts across the country to combat the youth vaping epidemic. IPVideo Corporation is headquartered in Bay Shore, NY. For more information, visit http://www.ipvideocorp.com.

About UL

As a global company with more than 120 years of expertise, we employ exacting scientific processes and the highest ethical principles to help create a better world. As safety challenges and concerns expand to include sustainability, well-being, connected technologies and security, we provide broad leadership, deep expertise and vital services to guide these transformations.

Fueled by our mission of working for a safer world, we are trusted partners in solving our customers’ and stakeholders’ most critical challenges. We believe that when choices are empowered by insight and opportunity, the potential to realize responsible innovation and better living is endless.

To fulfill our mission, UL delivers business solutions and our nonprofit conducts independent research and shares scientific knowledge broadly. For more information, visit http://www.ul.com

Share article on social media or email:

Allyn Rose and Kate Devine, M.D.

“For women like Allyn, genetic testing is a safe and reliable means of reducing the possibility of having children with the genetic mutation a parent or parents may carry. At SGF, we test each embryo for the specific gene mutation and the patient may opt to use the embryos that test negative.”

WASHINGTON (PRWEB)
October 31, 2019

The month of October, National Breast Cancer Awareness Month, serves as an important reminder that this year, an estimated 700,000 people in the U.S. will be diagnosed with breast cancer, of which, up to 10 percent of cases are linked to an inherited gene mutation. With advancements in fertility treatment and genetic testing, couples are now able to reduce the risk of passing along known genetic mutations to their children.

Shady Grove Fertility (SGF), a premier fertility and IVF center with 36 locations and home to more than 85,000 babies born, now offers patients the option to screen for over 280 recessive gene mutations, including diseases such as cystic fibrosis, Tay-Sachs disease, and spinal muscular atrophy. In addition, patients at risk for dominant gene mutations, such as breast cancer or inherited forms of colon cancer, can have individualized testing for these diseases. These tests can identify possible genetic diseases that may be passed on to their child(ren). If a genetic disease is found, the couple has the option to use in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects (PGT-M) to reduce the risk of passing that mutation onto their child(ren), thereby reducing their risk of disease in the future.

As part of its efforts to educate patients about the value of these interventions, and the availability of fertility preservation prior to any cancer treatment, SGF forged a new partnership with Allyn Rose, a breast cancer previvor, well known women’s health advocate, former Miss USA and Miss America contestant, and full-time model.

“I lost my precious mom, Judy Rose, to breast cancer when I was 16. One of the most challenging things about growing up without a mom is thinking that you’re going to have to face life’s special experiences alone. It’s especially true for a woman,” said Rose. “I understand the difficulties of having to become your own mentor, and I’m passionate about encouraging others to not allow trials in their lives to become negative defining moments, rather, use their adversity as inspiration.”

In addition to losing her mother during her teenage years, Rose also lost her grandmother and great aunt to breast cancer and knew she would want to take any measures to prevent herself and any children from suffering from the disease. As a 24 year old Miss America contestant, Rose made headlines when she made the difficult decision to undergo a prophylactic bilateral mastectomy. In 2018, Rose was selected as a Sports Illustrated Swing Search Finalist and became the first woman with a mastectomy to model for Sports Illustrated.

What Rose also knew was that her own experience gave her the motivation and platform to create a movement that encouraged other women to seek preventive healthcare. She created the #SelfExamGram social media movement, which spreads the message of early breast cancer detection and reminds women to perform monthly self breast exams.

Rose is now in the early stages of her IVF journey with Kate Devine, M.D. at SGF’s Washington, D.C. location, opting to undergo PGT-M to reduce the risk of having a child with an inherited condition.

“In the beginning, I was overwhelmed thinking about the entire process. But the team at Shady Grove Fertility, in their best Mom Voice, told me that ‘it was going to be okay’ and that I wasn’t alone.”

“This is an amazing experience to be able to help Allyn and her husband have children. For women like Allyn, genetic testing is a safe and reliable means of reducing the possibility of having children with the genetic mutation a parent or parents may carry. At SGF, we test each embryo for the specific gene mutation and the patient may opt to use the embryos that test negative,” explains Dr. Devine.

Rose is documenting her journey to motherhood with Dr. Devine and SGF in hope that it will lift the veil of the unknown associated with infertility treatment, and also serve as a reminder to women to be their own advocate. “I hope that it will ‘pay it forward’ to other women going through this and help them realize that they aren’t alone either.”

While Rose is cancer-free, SGF has a specially trained team that works specifically with people with cancer to ensure the fertility preservation process before cancer treatment can be expedited in order that cancer treatment can quickly begin. The oncofertility team at SGF helps to guide patients through each step of the treatment process, from finding ways to afford treatment to the actual medical procedure.

If you would like to learn more about SGF’s oncofertility treatment options or to schedule an appointment, please call the New Patient Center at 1-888-761-1967 or complete this brief online form.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 36 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

Share article on social media or email: